Role of zolpidem in the management of insomnia.

Amit Dang, Amit Garg, Padmanabh V Rataboli
Author Information
  1. Amit Dang: Department of Pharmacology, Goa Medical College, Goa, India. dramit_gmc@rediffmail.com

Abstract

Insomnia is a common condition that affects one's ability to sleep comfortably and consequently to work effectively. Its etiology is multifactorial and involves plethora of risk factors. Consequences can vary from mild sleepiness to more sever psychiatric disturbances and ischemic stroke. Despite several diagnostic criteria it is poorly diagnosed and less often treated. Benzodiazepines formed the mainline therapy for many years till the advent of newer nonbenzodiazepine group of drugs including zolpidem. Zolpidem is an imidazo-pyridine compound that enhances the GABA(A) receptor function by interaction with Omega-1 receptor subtype. Its pharmacokinetic profile allows the patients to use it later in the night when having trouble falling asleep without any residual cognitive impairment the next morning. It has rapid onset of action, improves total sleep duration, and reduces night-time awakenings. Its adverse effect profile is satisfactory as it appears to have low addiction potential. This review will focus on the current role of zolpidem in the management of insomnia.

References

J Clin Pharmacol. 1999 Feb;39(2):184-91 [PMID: 11563412]
Hum Psychopharmacol. 2001 Jul;16(5):369-392 [PMID: 12404558]
J Neurochem. 1990 May;54(5):1802-4 [PMID: 2157817]
J Consult Clin Psychol. 1992 Aug;60(4):586-94 [PMID: 1506506]
CNS Drugs. 2004;18 Suppl 1:35-40; discussion 41, 43-5 [PMID: 15291012]
Psychiatr Serv. 1999 Mar;50(3):421 [PMID: 10096658]
Sleep Med. 2005 Sep;6(5):435-41 [PMID: 16085459]
Sleep. 2008 Jan;31(1):79-90 [PMID: 18220081]
Biol Psychol. 2001 Jul-Aug;57(1-3):67-103 [PMID: 11454435]
Sleep. 1999 May 1;22 Suppl 2:S344-5 [PMID: 10394605]
J Neurosci. 1999 Jan 15;19(2):578-88 [PMID: 9880578]
J Clin Psychiatry. 1995 Jan;56(1):35-6 [PMID: 7836339]
Hosp Pract (1995). 1998 Dec 15;33(12):75-8, 83-6 [PMID: 9866648]
Int J Eat Disord. 2009 May;42(4):385-6 [PMID: 19107832]
J Am Geriatr Soc. 2001 Dec;49(12):1685-90 [PMID: 11844004]
J Clin Psychiatry. 1994 May;55(5):192-9 [PMID: 8071269]
J Clin Psychiatry. 1992 Dec;53 Suppl:4-7; discussion 8-9 [PMID: 1487479]
Cochrane Database Syst Rev. 2009 Jan 21;(1):MR000006 [PMID: 19160345]
Eur Psychiatry. 1997;12 Suppl 1:5-14 [PMID: 19698569]
Sleep Med Rev. 2002 Apr;6(2):97-111 [PMID: 12531146]
J Int Med Res. 1998 Jan-Feb;26(1):13-24 [PMID: 9513073]
Am Fam Physician. 1999 Apr 1;59(7):1911-6, 1918 [PMID: 10208709]
Neuropsychobiology. 2000;41(3):139-48 [PMID: 10754428]
J Am Geriatr Soc. 2000 Oct;48(10):1234-40 [PMID: 11037010]
N Engl J Med. 1997 Jan 30;336(5):341-6 [PMID: 9011788]
Lancet. 1993 Aug 14;342(8868):443-4 [PMID: 8101949]
J Clin Psychiatry. 2001;62 Suppl 10:3-4 [PMID: 11388588]
J Psychopharmacol. 1998;12(1):103-4 [PMID: 9584975]
Fundam Clin Pharmacol. 2006 Aug;20(4):397-403 [PMID: 16867025]
J Clin Psychopharmacol. 2006 Jun;26(3):284-9 [PMID: 16702893]
J Clin Psychopharmacol. 2002 Dec;22(6):576-83 [PMID: 12454557]
Am J Hosp Palliat Care. 2003 Sep-Oct;20(5):382-8 [PMID: 14529041]
Am J Med. 2008 Nov;121(11):e5 [PMID: 18954831]
Evid Rep Technol Assess (Summ). 2005 Jun;(125):1-10 [PMID: 15989374]
Sleep. 1993 Apr;16(3):226-32 [PMID: 8506455]
Hum Psychopharmacol. 2003 Jul;18(5):369-74 [PMID: 12858323]
Int J Clin Exp Hypn. 2008 Jul;56(3):270-80 [PMID: 18569138]
Arch Intern Med. 2005 Apr 25;165(8):863-7 [PMID: 15851636]
Psychophysiology. 2001 Nov;38(6):979-87 [PMID: 12240674]
Lancet. 1992 Mar 28;339(8796):809 [PMID: 1347827]
Drugs Aging. 2005;22(9):749-65 [PMID: 16156679]
Lancet. 1993 Aug 7;342(8867):374-5 [PMID: 8101619]
JAMA. 1997 Dec 24-31;278(24):2170-7 [PMID: 9417012]
Addiction. 2003 Oct;98(10):1371-8 [PMID: 14519173]
Sleep. 1995 May;18(4):246-51 [PMID: 7618022]
J Psychiatr Res. 2003 Jan-Feb;37(1):9-15 [PMID: 12482465]
Psychopharmacology (Berl). 1996 Nov;128(1):1-16 [PMID: 8944400]
J Epidemiol Community Health. 2006 Jan;60(1):69-73 [PMID: 16361457]
J Psychosom Res. 2001 Dec;51(6):745-55 [PMID: 11750297]
Psychiatr Serv. 2005 Mar;56(3):332-43 [PMID: 15746509]
Clin Pharmacokinet. 1995 Sep;29(3):142-53 [PMID: 8521677]
J Am Geriatr Soc. 2001 Sep;49(9):1185-9 [PMID: 11559377]
Lancet. 2004 Nov 27-Dec 3;364(9449):1959-73 [PMID: 15567013]
Sleep. 2008 Sep;31(9):1277-84 [PMID: 18788653]
J Pharmacol Exp Ther. 1990 Dec;255(3):1246-55 [PMID: 2262904]
Sleep. 2005 Sep;28(9):1049-57 [PMID: 16268373]
Eur Psychiatry. 1997;12 Suppl 1:15-20 [PMID: 19698570]
Hum Psychopharmacol. 2008 Dec;23(8):693-705 [PMID: 18763235]
J Clin Psychiatry. 1999 Oct;60(10):668-76 [PMID: 10549683]
J Clin Sleep Med. 2008 Apr 15;4(2):155-6 [PMID: 18468314]
Hum Psychopharmacol. 2001 Mar;16(2):169-176 [PMID: 12404587]
Sleep Med. 2001 Sep;2(5):423-30 [PMID: 14592392]
J Clin Psychiatry. 2004 Aug;65(8):1128-37 [PMID: 15323600]
J Psychopharmacol. 1999;13(1):81-93 [PMID: 10221362]
Aviat Space Environ Med. 2001 Jul;72(7):638-46 [PMID: 11471907]
Aviat Space Environ Med. 1996 Feb;67(2):115-20 [PMID: 8834935]
Exp Clin Psychopharmacol. 2003 Nov;11(4):259-68 [PMID: 14599259]
Sleep. 2002 Aug 1;25(5):553-63 [PMID: 12150322]
CNS Drugs. 2006;20(7):567-90 [PMID: 16800716]
Psychother Psychosom. 2009;78(3):172-81 [PMID: 19321970]
J Sleep Res. 2005 Mar;14(1):49-59 [PMID: 15743334]
Aust N Z J Psychiatry. 2009 May;43(5):426-30 [PMID: 19373703]
J Clin Psychopharmacol. 2009 Jun;29(3):222-30 [PMID: 19440075]
J Clin Sleep Med. 2007 Aug 15;3(5 Suppl):S11-5 [PMID: 17824496]
Drugs. 2000 Apr;59(4):865-89 [PMID: 10804040]
Neurosci Res. 2007 Nov;59(3):309-13 [PMID: 17825448]
Psychopharmacology (Berl). 2005 Aug;181(1):21-6 [PMID: 15830236]
J Clin Psychopharmacol. 2000 Jun;20(3):328-37 [PMID: 10831020]

MeSH Term

Animals
Disease Management
Humans
Hypnotics and Sedatives
Pyridines
Sleep Initiation and Maintenance Disorders
Sleep Stages
Zolpidem

Chemicals

Hypnotics and Sedatives
Pyridines
Zolpidem

Word Cloud

Similar Articles

Cited By